| 000 | 01687 a2200421 4500 | ||
|---|---|---|---|
| 005 | 20250516142555.0 | ||
| 264 | 0 | _c20130523 | |
| 008 | 201305s 0 0 eng d | ||
| 022 | _a1534-4436 | ||
| 024 | 7 |
_a10.1016/j.anai.2013.02.007 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aRiedl, Marc A | |
| 245 | 0 | 0 |
_aEfficacy and safety of recombinant C1 inhibitor for the treatment of hereditary angioedema attacks: a North American open-label study. _h[electronic resource] |
| 260 |
_bAnnals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology _cApr 2013 |
||
| 300 |
_a295-9 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAdolescent |
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 |
_aAngioedemas, Hereditary _xdrug therapy |
| 650 | 0 | 4 |
_aComplement C1 Inhibitor Protein _xadministration & dosage |
| 650 | 0 | 4 | _aDouble-Blind Method |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 | _aNorth America |
| 650 | 0 | 4 |
_aRecombinant Proteins _xadministration & dosage |
| 650 | 0 | 4 | _aTreatment Outcome |
| 650 | 0 | 4 | _aYoung Adult |
| 700 | 1 | _aLevy, Robyn J | |
| 700 | 1 | _aSuez, Daniel | |
| 700 | 1 | _aLockey, Richard F | |
| 700 | 1 | _aBaker, James W | |
| 700 | 1 | _aRelan, Anurag | |
| 700 | 1 | _aZuraw, Bruce L | |
| 773 | 0 |
_tAnnals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology _gvol. 110 _gno. 4 _gp. 295-9 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.anai.2013.02.007 _zAvailable from publisher's website |
| 999 |
_c22620611 _d22620611 |
||